Averett; Devron R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Averett; Devron R..The latest application filed is for "reduction of infections in healthcare settings using photocatalytic compositions".

Company Profile

0.21.23

Averett; Devron R. - Berkley CA
Averett; Devron R. - Berkeley CA
Averett; Devron R. - Cardiff by the Sea CA
Averett, Devron R. - San Diego CA
Averett; Devron R. - Raleigh NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Reduction of infections in healthcare settings using photocatalytic compositions Grant 10,434,203 - Averett , et al. O	2019-10-08
Titanium dioxide photocatalytic compositions and uses thereof Grant 9,833,003 - Averett , et al. December 5, 2	2017-12-05
Reduction Of Infections In Healthcare Settings Using Photocatalytic Compositions App 20160375164 - Averett; Stewart Benson ; et al.	2016-12-29
Titanium Dioxide Photocatalytic Compositions and Uses Thereof App 20160302422 - Averett; Stewart Benson ; et al.	2016-10-20
Titanium dioxide photocatalytic compositions and uses thereof Grant 9,402,400 - Averett , et al. August 2, 2	2016-08-02
Titanium dioxide photocatalytic compositions and uses thereof Grant 9,392,795 - Averett , et al. July 19, 2	2016-07-19
Titanium Dioxide Photocatalytic Compositions and Uses Thereof App 20160015037 - Averett; Stewart Benson ; et al.	2016-01-21
Reduction Of Infections In Healthcare Settings Using Photocatalytic Compositions App 20150367007 - Averett; Stewart B. ; et al.	2015-12-24
Titanium dioxide photocatalytic compositions and uses thereof Grant 9,144,242 - Averett , et al. September 29, 2	2015-09-29
Titanium Dioxide Photocatalytic Compositions and Uses Thereof App 20150245617 - Averett; Stewart Benson ; et al.	2015-09-03
Titanium dioxide photocatalytic compositions and uses thereof Grant 9,055,751 - Averett , et al. June 16, 2	2015-06-16
Titanium Dioxide Photocatalytic Compositions and Uses Thereof App 20140099348 - Averett; Stewart Benson ; et al.	2014-04-10
Titanium Dioxide Photocatalytic Compositions and Uses Thereof App 20140093551 - Averett; Stewart Benson ; et al.	2014-04-03
Titanium dioxide photocatalytic compositions and uses thereof Grant 8,609,121 - Averett , et al. December 17, 2	2013-12-17
Titanium Dioxide Photocatalytic Compositions And Uses Thereof App 20120308630 - Averett; Steward B. ; et al.	2012-12-06
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 8,211,863 - Averett July 3, 2	2012-07-03
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20120028999 - Averett; Devron R.	2012-02-02
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 8,034,802 - Averett October 11, 2	2011-10-11
3-.beta.-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof Grant 7,943,759 - Averett , et al. May 17, 2	2011-05-17
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 7,858,637 - Averett December 28, 2	2010-12-28
3- -D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF App 20100261667 - Averett; Devron R. ; et al.	2010-10-14
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20100256169 - Averett; Devron R.	2010-10-07
3-.beta.-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof Grant 7,745,415 - Averett , et al. June 29, 2	2010-06-29
Administration Of Tlr7 Ligands And Prodrugs Thereof For Treatment Of Infection By Hepatitis C Virus App 20090298863 - Averett; Devron R.	2009-12-03
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus Grant 7,576,068 - Averett August 18, 2	2009-08-18
3-beta-D-Ribofuranosylthiazalo [4-5-d] pyrimidine nucleosides and uses thereof App 20080090844 - Averett; Devron R. ; et al.	2008-04-17
3-Beta-D-Ribofuranosylthiazolo[4,5-D]Pyridimine Nucleosides and Uses Thereof App 20080070852 - Averett; Devron R. ; et al.	2008-03-20
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof Grant 7,321,033 - Averett , et al. January 22, 2	2008-01-22
Nucleoside phosphonate derivatives useful in the treatment of HIV infections App 20060052346 - Averett; Devron R.	2006-03-09
3-beta-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and uses thereof App 20050182001 - Averett, Devron R. ; et al.	2005-08-18
3-.beta.-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof Grant 6,924,271 - Averett , et al. August 2, 2	2005-08-02
3-B-D-ribofuranosylthiazolo [4,5-d] pyridimine nucleosides and uses thereof App 20050070556 - Averett, Devron R. ; et al.	2005-03-31
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus App 20050054590 - Averett, Devron R.	2005-03-10
3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof App 20030199461 - Averett, Devron R. ; et al.	2003-10-23
Purine L-nucleosides, analogs and uses thereof App 20020058635 - Averett, Devron R.	2002-05-16
Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives Grant 5,492,897 - Krenitsky , et al. February 20, 1	1996-02-20
Antiviral combinations Grant 4,758,572 - Spector , et al. July 19, 1	1988-07-19

Company Registrations

SEC

0001283302

AVERETT DEVRON R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.